If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
From the publishers of Nature<br /> nature.com/biopharmadealmakers | March 2016<br /> Dedicated to nurturing collaboration and partnerships in the biopharma industry<br /> No stone unturned in the search for winning<br /> immuno-oncology combination therapies<br /> Originally published as an advertising feature in the March 2016 editions ofRegister Today!<br /> APRIL 17–20, 2016<br /> SAN DIEGO CONVENTION CENTER<br /> Join leaders in renewable chemicals,<br /> advanced biofuels, biobased materials<br /> and more in San Diego for the largest<br /> industrial biotechnology conference!<br /> Visit our website to receive discounted<br /> Early Bird rates until March 17th.<br /> bio.org/worldcongress #BIOWC16From the publishers of Nature<br /> nature.com/biopharmadealmakers | March 2016<br /> Dedicated to nurturing collaboration and partnerships in the biopharma indu<a title="BioPharma Dealmakers March 2016 page 1" href="http://viewer.zmags.com/publication/d54a8b39?page=1">From the publishers of Nature </a> <a title="BioPharma Dealmakers March 2016 page 2" href="http://viewer.zmags.com/publication/d54a8b39?page=2">Register Today! APRIL 17–20, 2016 SAN DIEGO CO</a> <a title="BioPharma Dealmakers March 2016 page 3" href="http://viewer.zmags.com/publication/d54a8b39?page=3">From the publishers of Nature </a> <a title="BioPharma Dealmakers March 2016 page 4" href="http://viewer.zmags.com/publication/d54a8b39?page=4">Immuno-oncology dominates big pharma’s deal agend</a> <a title="BioPharma Dealmakers March 2016 page 5" href="http://viewer.zmags.com/publication/d54a8b39?page=5">Group, a strategy-consulting firm. Every tumor typ</a> <a title="BioPharma Dealmakers March 2016 page 6" href="http://viewer.zmags.com/publication/d54a8b39?page=6">feature Rapid turnover Novartis CEO Joseph Jim</a> <a title="BioPharma Dealmakers March 2016 page 7" href="http://viewer.zmags.com/publication/d54a8b39?page=7">ADVERTISEMENT FEATURE OncoSec Medical I</a> <a title="BioPharma Dealmakers March 2016 page 8" href="http://viewer.zmags.com/publication/d54a8b39?page=8">profile Toronto-based InDanio Bioscience Inc. use</a> <a title="BioPharma Dealmakers March 2016 page 9" href="http://viewer.zmags.com/publication/d54a8b39?page=9">ADVERTISEMENT FEATURE Synaffix BV www.</a> <a title="BioPharma Dealmakers March 2016 page 10" href="http://viewer.zmags.com/publication/d54a8b39?page=10">profile OncoTherapy Science, Inc. (OTS) is appr</a> <a title="BioPharma Dealmakers March 2016 page 11" href="http://viewer.zmags.com/publication/d54a8b39?page=11">ADVERTISEMENT FEATURE optimized small-molec</a> <a title="BioPharma Dealmakers March 2016 page 12" href="http://viewer.zmags.com/publication/d54a8b39?page=12">profile Netherlands-based ISA Pharmaceuticals i</a> <a title="BioPharma Dealmakers March 2016 page 13" href="http://viewer.zmags.com/publication/d54a8b39?page=13">ADVERTISEMENT FEATURE Andes Biotechnolo</a> <a title="BioPharma Dealmakers March 2016 page 14" href="http://viewer.zmags.com/publication/d54a8b39?page=14">profile The immunotherapy of cancer has recentl</a> <a title="BioPharma Dealmakers March 2016 page 15" href="http://viewer.zmags.com/publication/d54a8b39?page=15">ADVERTISEMENT FEATURE SINGLE CELL TECHNOLOGY </a> <a title="BioPharma Dealmakers March 2016 page 16" href="http://viewer.zmags.com/publication/d54a8b39?page=16">There's no better place to connect with biotech's </a>